Found 9 matching trials
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
PHASE1The drugs GSK189075 and GW869682 result in increased caloric losses. This s...
Location
GSK Investigational Site
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
PHASE1The purpose of this research study is to look at concentrations of GSK18907...
Location
GSK Investigational Site
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
PHASE2This is a dose-ranging study to evaluate the efficacy, safety and tolerabil...
Location
GSK Investigational Site
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
PHASE2This is a study to compare the safety, blood concentrations, and effects of...
Location
GSK Investigational Site
A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults
PHASE1This study assesses for change in heart rhythm of healthy volunteers taking...
Location
GSK Investigational Site
A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
PHASE1This study will assess safety and tolerability of metformin plus GSK189075 ...
Location
GSK Investigational Site
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
PHASE2This is a dose-ranging study that will evaluate the efficacy, safety and to...
Location
GSK Investigational Site
A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
PHASE2The purpose of this research study is to look at concentrations of GSK18907...
Location
GSK Investigational Site
A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
PHASE1This study will assess safety and tolerability when taking GSK189075 at dos...
Location
GSK Investigational Site